Free Trial

Titan Pharmaceuticals (TTNP) SEC Filings & 10K Form

Titan Pharmaceuticals logo
$3.70 -0.09 (-2.37%)
Closing price 04/25/2025 03:52 PM Eastern
Extended Trading
$3.98 +0.28 (+7.43%)
As of 04/25/2025 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Titan Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/22/2025
3:45 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
3:30 PM
Titan Pharmaceuticals (Filer)
Form PRE 14A
04/16/2025
2:49 PM
Jye Chay Weei (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2025
3:30 PM
Titan Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/08/2025
3:05 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:10 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
8:16 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
7:32 AM
Sire Group Ltd. (Filed by)
Titan Pharmaceuticals (Subject)
Form SC 13D/A
08/15/2024
8:29 AM
Titan Pharmaceuticals (Filer)
Form NT 10-Q
08/15/2024
8:29 AM
Titan Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
8:39 AM
Titan Pharmaceuticals (Filer)
Form RW
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TTNP) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners